Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
US Patent Number
10,772,940
Publication Date
9-15-2020
Abstract
The presently-disclosed subject matter includes isolated polypeptides that comprise a butyrylcholinestrase (BChE) polypeptide and a second polypeptide. The BChE polypeptide as well as the second polypeptide can be variants and/or fragments thereof. The presently-disclosed subject matter also includes a pharmaceutical composition that comprises the present isolated polypeptide and a suitable pharmaceutical carrier. Further still, methods are provided for treating cocaine-induced conditions, and comprise administering the isolated polypeptide and/or pharmaceutical compositions thereof to an individual.
Assignees
University of Kentucky Research Foundation, Lexington, KY (US)
Application Number
14/102,977
Filing Date
12-11-2013
Recommended Citation
Zhan, Chang-Guo; Zheng, Fang; Tai, Hsin-Hsiung; Chen, Xiabin; Xue, Liu; and Hou, Shurong, "Cocaine Hydrolase-Fc Fusion Proteins for Cocaine and Methods for Utilizing the Same" (2020). Pharmaceutical Sciences Faculty Patents. 192.
https://uknowledge.uky.edu/ps_patents/192
